Safety and Efficacy of Systemic Anti-Scg3 Therapy to Treat Oxygen-Induced Retinopathy

Background: To circumvent possible systemic side effects, anti-angiogenic drugs targeting vascular endothelial growth factor (VEGF) for ocular neovascular diseases in adults are approved only for intravitreal administration. However, intravitreal injection itself can elicit injection-related adverse...

Full description

Saved in:
Bibliographic Details
Main Authors: Chang Dai, Hong Tian, Amit Bhatt, Guanfang Su, Keith A. Webster, Wei Li
Format: Artigo
Language:Inglês
Published: IMR Press 2022-04-01
Series:Frontiers in Bioscience-Landmark
Subjects:
retinopathy of prematurity
oxygen-induced retinopathy
secretogranin iii
scg3
pathological angiogenesis
physiological angiogenesis
targeted anti-angiogenic therapy
Online Access:https://www.imrpress.com/journal/FBL/27/4/10.31083/j.fbl2704130
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items